Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis

被引:65
作者
de Waha, Suzanne [1 ,2 ]
Jobs, Alexander [1 ,2 ]
Eitel, Ingo [1 ,2 ]
Poess, Janine [1 ,2 ]
Stiermaier, Thomas [1 ,2 ]
Meyer-Saraei, Roza [1 ,2 ]
Fuernau, Georg [1 ,2 ]
Zeymer, Uwe [3 ]
Desch, Steffen [1 ,2 ]
Thiele, Holger [1 ,2 ,4 ]
机构
[1] Univ Hosp Schleswig Holstein, Univ Heart Ctr Luebeck, Dept Cardiol Angiol & Intens Care Med, Ratzeburger Allee 160, D-23538 Lubeck, Germany
[2] Partner Site Hamburg Kiel Luebeck, German Ctr Cardiovasc Res DZHK, Lubeck, Germany
[3] Klinikum Ludwigshafen, Med Klin B, Ludwigshafen, Germany
[4] Univ Leipzig, Dept Internal Med Cardiol, Heart Ctr Leipzig, Leipzig, Germany
关键词
Multivessel coronary artery disease; acute myocardial infarction; cardiogenic shock; reperfusion; percutaneous coronary intervention; REVASCULARIZATION; PCI; COUNTERPULSATION; MANAGEMENT; OUTCOMES;
D O I
10.1177/2048872617719640
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Early revascularisation of the culprit lesion is the therapeutic cornerstone in cardiogenic shock complicating acute myocardial infarction. The optimal management of additional non-culprit lesions is unclear. This systematic review and meta-analysis aims to summarise current evidence on the comparison of immediate multivessel percutaneous coronary intervention (MV-PCI) or culprit lesion only PCI with possible staged revascularisation (C-PCI) in patients with cardiogenic shock complicating acute myocardial infarction. Methods: Medical literature databases were screened to identify analyses comparing MV-PCI with C-PCI in patients with cardiogenic shock complicating acute myocardial infarction and multivessel coronary artery disease. In absence of randomised trials, 10 cohort studies were included in the current meta-analysis. The primary outcome of short-term mortality was assessed at hospital discharge or 30 days after hospital admission. Secondary outcomes were long-term mortality as well as myocardial re-infarction, stroke, acute renal failure, and bleeding at short-term follow-up. Results: Of 6051 patients, 1194 (19.7%) received MV-PCI and 4857 (80.3%) C-PCI. Short-term mortality was 37.5% in patients undergoing MV-PCI compared with 28.8% in C-PCI patients (risk ratio 1.26, 95% confidence interval 1.12-1.41, p=0.001). Long-term mortality (p=0.77), myocardial re-infarction (p=0.77), stroke (p=0.12), acute renal failure (p=0.17) and bleeding (p=0.53) did not differ significantly between the two revascularisation groups. Conclusions: Results of this first meta-analysis on the interventional management of patients with cardiogenic shock complicating acute myocardial infarction and multivessel coronary artery disease do not support MV-PCI over C-PCI. However, possible treatment selection bias in the individual studies must be taken into account.
引用
收藏
页码:28 / 37
页数:10
相关论文
共 25 条
[1]  
[Anonymous], 2017, J AM COLL CARDIOL, DOI DOI 10.1016/j.jacc.2016.10.034
[2]  
[Anonymous], 2014, J AM COLL CARDIOL, DOI DOI 10.1016/j.jacc.2014.09.016
[3]  
[Anonymous], EUR HEART J ACUTE CA
[4]   Use and Outcomes of Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (from the EHS-PCI Registry) [J].
Bauer, Timm ;
Zeymer, Uwe ;
Hochadel, Matthias ;
Moellmann, Helge ;
Weidinger, Franz ;
Zahn, Ralf ;
Nef, Holger M. ;
Hamm, Christian W. ;
Marco, Jean ;
Gitt, Anselm K. .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07) :941-946
[5]  
Cavender MA, 2013, J INVASIVE CARDIOL, V25, P218
[6]   Prevalence, Predictors, and In-Hospital Outcomes of Non-Infarct Artery Intervention During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction (from the National Cardiovascular Data Registry) [J].
Cavender, Matthew A. ;
Milford-Beland, Sarah ;
Roe, Matthew T. ;
Peterson, Eric D. ;
Weintraub, William S. ;
Rao, Sunil V. .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (04) :507-513
[7]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[8]   Quantifying heterogeneity in a meta-analysis [J].
Higgins, JPT ;
Thompson, SG .
STATISTICS IN MEDICINE, 2002, 21 (11) :1539-1558
[9]   Early revascularization in acute myocardial infarction complicated by cardiogenic shock [J].
Hochman, JS ;
Sleeper, LA ;
Webb, JG ;
Sanborn, TA ;
White, HD ;
Talley, JD ;
Buller, CE ;
Jacobs, AK ;
Slater, JN ;
Col, J ;
McKinlay, SM ;
LeJemtel, TH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (09) :625-634
[10]  
Kolh P., 2014, Eur J Cardiothorac Surg, V46, P517, DOI [10.1093/ejcts/ezu366, DOI 10.1093/EJCTS/EZU366]